RODINO-KLAPAC LOUISE 1836218 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-20 | 2023-11-17 | 2023-11-17 | 4 | Rodino Klapac Louise | HEAD OF R&D, CSO | dsp | 4508.0 | 6.42 | 0.48 | 82.98 | Direct | Common Stock | SAREPTA THERAPEUTICS, INC. | code F | 65751.0 | 93.55 (SRPT) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Rodino Klapac Louise | HEAD OF R&D, CSO | dsp | 778.0 | 1.18 | 0.08 | 126.19 | Direct | Common Stock | SAREPTA THERAPEUTICS, INC. | code F | 65222.0 | 93.55 (SRPT) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Rodino Klapac Louise | HEAD OF R&D, CSO | acq | 6000.0 | 8.42 | 0.64 | 0.0 | Direct | Common Stock | SAREPTA THERAPEUTICS, INC. | code A | 71222.0 | 93.55 (SRPT) |
| 2024-03-06 | 2024-03-04 | 2024-03-04 | 4 | Rodino Klapac Louise | HEAD OF R&D, CSO | dsp | 1728.0 | 2.43 | 0.18 | 125.32 | Direct | Common Stock | SAREPTA THERAPEUTICS, INC. | code F | 69494.0 | 93.55 (SRPT) |
| 2024-03-11 | 2024-03-07 | 2024-03-07 to 2024-03-08 | 4 | Rodino Klapac Louise | HEAD OF R&D, CSO | dsp | 1421.0 | 2.04 | 0.15 | 122.19 | Direct | Common Stock | SAREPTA THERAPEUTICS, INC. | code F | 68073.0
|
93.55 (SRPT) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Rodino Klapac Louise | HEAD OF R&D, CSO | acq | 12500.0 | 100.0 | 1.34 | 128.67 | Direct | Stock Option (Right To Buy) | SAREPTA THERAPEUTICS, INC. | code A | 12500.0 | 93.55 (SRPT) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)